See more : IMURA & Co.,Ltd. (3955.T) Income Statement Analysis – Financial Results
Complete financial analysis of Solanbridge Group, Inc. (SLNX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Solanbridge Group, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- AH-Vest Limited (AHL.JO) Income Statement Analysis – Financial Results
- China National Software & Service Company Limited (600536.SS) Income Statement Analysis – Financial Results
- Martin Currie Global Portfolio Trust plc (MNP.L) Income Statement Analysis – Financial Results
- JG Environmental Technology Co.,Ltd. (6723.TWO) Income Statement Analysis – Financial Results
- New Horizon Aircraft Ltd. (HOVRW) Income Statement Analysis – Financial Results
Solanbridge Group, Inc. (SLNX)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.solanbridgegroup.com
About Solanbridge Group, Inc.
Solanbridge Group, Inc. intends to produce and sell medical marijuana in Nova Scotia, Canada. It also focuses on the development and sale of CBD-infused products in Nevada, California, and Colorado. The company was founded in 2000 and is headquartered in The Woodlands, Texas.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2014 | 2013 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 229.07K | 557.34K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 98.18K | 306.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 130.90K | 250.88K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 57.14% | 45.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 60.00 | 16.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 131.65K | 216.12K | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 60.00 | 16.50 | 6.63K | 6.74K | 7.27K | 7.46K | 7.57K | 84.40K | 133.81K | 131.65K | 216.12K | 136.70K | 229.98K | 77.71K | 114.66K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -27.30K | -45.39K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 67.75 | 25.04 | 6.63K | 6.74K | 7.27K | 7.46K | 7.57K | 111.70K | 179.20K | 131.65K | 216.89K | 136.70K | 229.98K | 77.71K | 114.66K |
| Cost & Expenses | 67.75 | 25.04 | 6.63K | 6.74K | 7.27K | 7.46K | 7.57K | 209.87K | 485.65K | 131.65K | 216.89K | 136.70K | 229.98K | 77.71K | 114.66K |
| Interest Income | 0.00 | 9.62 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 11.00 | 11.00 | 60.00 | 88.00 | 104.00 | 8.85K | 136.56K | 112.69K | 2.97K | 3.90K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 60.00 | 16.50 | 206.30K | 171.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.08K | 0.00 | 438.00 | 1.95K |
| EBITDA | -67.75K | -18.16 | -6.62K | -6.74K | -7.27K | -7.46K | -7.57K | 6.71K | 71.68K | -130.24K | -216.89K | -135.62K | -229.98K | -77.28K | -112.71K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 8.38% | 12.86% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -60.00 | -16.50 | -6.62K | -6.74K | -7.26K | -7.46K | -7.57K | 19.20K | 71.68K | -131.65K | -216.89K | -136.70K | -229.98K | -77.71K | -114.66K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 8.38% | 12.86% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -67.69K | -18.16 | -16.00 | -6.00 | -65.00 | -85.00 | -100.00 | -21.35K | -136.56K | -111.28K | -2.97K | -4.97K | 0.00 | -438.00 | -1.95K |
| Income Before Tax | -67.75K | -34.66 | -6.64K | -6.75K | -7.33K | -7.55K | -7.67K | -2.15K | -64.88K | -242.93K | -219.86K | -137.77K | 0.00 | -78.15K | -116.61K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.94% | -11.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -18.16 | -206.30K | -171.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.90K | 229.98K | 0.00 | 0.00 |
| Net Income | -67.75 | -34.66 | -6.64K | -6.75K | -7.33K | -7.55K | -7.67K | -2.15K | -64.88K | -242.93K | -219.86K | -141.67K | -229.98K | -78.15K | -116.61K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.94% | -11.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 | -0.02 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | -0.02 | -0.01 | -0.02 | -0.01 | -0.02 |
| Weighted Avg Shares Out | 4.84M | 3.15M | 2.61B | 2.61B | 2.61B | 2.61B | 2.61B | 1.79B | 2.55B | 12.30M | 12.30M | 12.03M | 11.20M | 8.07M | 7.52M |
| Weighted Avg Shares Out (Dil) | 4.76M | 3.14M | 2.61B | 2.61B | 2.61B | 2.61B | 2.61B | 1.79B | 2.55B | 12.30M | 12.30M | 12.03M | 11.20M | 8.07M | 7.52M |
Source: https://incomestatements.info
Category: Stock Reports